Rein Therapeutics's total assets for Q2 2025 were $57.48M, a decrease of -0.26% from the previous quarter. RNTX total liabilities were $54.47M for the fiscal quarter, a 3.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.